Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Nov 27, 2009

NEW YORK (GenomeWeb News) – Susan Shurin will begin serving as acting director of the National Heart, Lung, and Blood Institute effective Dec. 1, according to a letter sent to the institute's staff by NIH Director Francis Collins last week. Shurin has been deputy director of NHLBI since February 2006, and is taking over for Elizabeth Nabel, who is leaving the institute to become president of Brigham and Women's/Faulkner Hospitals in Boston.

Collins also notified staff that Alan Guttmacher has agreed to become acting director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Guttmacher had been serving as acting director of the National Human Genome Research Institute since August 2008.

As reported last week by GenomeWeb Daily News, Eric Green was tapped by Collins to serve as director of NHGRI, effective Dec. 1.


Harvard University spinout Ligon Discovery has appointed Errol De Souza as its executive chairman of the board. De Souza has held senior level R&D and management positions at Aventis, Hoechst Marion Roussel, DuPont Merck, Neurocrine Biosciences, Synaptic Pharmaceuticals, and Archemix.


Enigma Diagnostics has hired Jorge Garces to serve as president and CEO of its newly established US operations, with Greg Hamilton serving as COO and CFO. Garces was most recently VP of R&D and site operations manager for Hologic. Hamilton was VP of operations, planning, and analysis for Hologic's business unit focus on women's healthcare products. He also previously served as VP of finance and operations at Third Wave Technologies, which was acquired for $582 million by Hologic in 2008.

In addition, the firm said that Nick Williams has joined as CFO Europe, and Darren Hall has joined as COO Europe. Williams has held senior finance roles at Calyx, Truflo International, and Biocompatibles. Hall has worked for Graseby, Smiths Industries, and Biocompatibles.


Enzo Biochem said that it has terminated Shahram Rabbani's services as the company's secretary and treasurer, effective immediately. He will continue to serve as a director of the firm, though.

Enzo said that its Chairman and CEO, Elazar Rabbani, will serve as secretary, while its President and CFO, Barry Weiner, will serve as treasurer.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.